Moisand Fitzgerald Tamayo’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $91.1K | Buy |
362
+68
| +23% | +$14.6K | 0.01% | 169 |
|
|
2026
Q1 | $63.9K | Sell |
294
-20
| -6% | -$4.44K | 0.01% | 180 |
|
|
2025
Q4 | $71.7K | Hold |
314
| – | – | 0.01% | 169 |
|
|
2025
Q3 | $72.7K | Buy |
314
+20
| +7% | +$4.07K | 0.01% | 167 |
|
|
2025
Q2 | $54.6K | Hold |
294
| – | – | 0.01% | 187 |
|
|
2025
Q1 | $61.6K | Hold |
294
| – | – | 0.01% | 171 |
|
|
2024
Q4 | $52.2K | Hold |
294
| – | – | 0.01% | 180 |
|
|
2024
Q3 | $58.1K | Hold |
294
| – | – | 0.01% | 176 |
|
|
2024
Q2 | $50.4K | Hold |
294
| – | – | 0.01% | 173 |
|
|
2024
Q1 | $53.5K | Sell |
294
-20
| -6% | -$3.45K | 0.01% | 173 |
|
|
2023
Q4 | $48.7K | Hold |
314
| – | – | 0.01% | 177 |
|
|
2023
Q3 | $46.8K | Buy |
314
+20
| +7% | +$2.94K | 0.01% | 185 |
|
|
2023
Q2 | $39.6K | Hold |
294
| – | – | 0.01% | 192 |
|
|
2023
Q1 | $46.9K | Hold |
294
| – | – | 0.01% | 183 |
|
|
2022
Q4 | $47.5K | Buy |
294
+122
| +71% | +$18.7K | 0.01% | 176 |
|
|
2022
Q3 | $23K | Buy |
172
+119
| +225% | +$17.1K | 0.01% | 215 |
|
|
2022
Q2 | $8K | Sell |
53
-15
| -22% | -$2.29K | ﹤0.01% | 283 |
|
|
2022
Q1 | $11K | Buy |
68
+32
| +89% | +$4.65K | 0.01% | 172 |
|
|
2021
Q4 | $5K | Hold |
36
| – | – | ﹤0.01% | 295 |
|
|
2021
Q3 | $4K | Hold |
36
| – | – | ﹤0.01% | 302 |
|
|
2021
Q2 | $4K | Hold |
36
| – | – | ﹤0.01% | 324 |
|
|
2021
Q1 | $4K | Sell |
36
-66
| -65% | -$7.06K | ﹤0.01% | 272 |
|
|
2020
Q4 | $11K | Sell |
102
-25
| -20% | -$2.4K | 0.01% | 203 |
|
|
2020
Q3 | $11K | Buy |
127
+91
| +253% | +$8.57K | 0.01% | 183 |
|
|
2020
Q2 | $4K | Hold |
36
| – | – | ﹤0.01% | 230 |
|
|
2020
Q1 | $3K | Hold |
36
| – | – | ﹤0.01% | 212 |
|
|
2019
Q4 | $3K | Hold |
36
| – | – | ﹤0.01% | 236 |
|
|
2019
Q3 | $3K | Hold |
36
| – | – | ﹤0.01% | 237 |
|
|
2019
Q2 | $3K | Hold |
36
| – | – | ﹤0.01% | 236 |
|
|
2019
Q1 | $3K | Hold |
36
| – | – | ﹤0.01% | 239 |
|
|
2018
Q4 | $3K | Hold |
36
| – | – | ﹤0.01% | 234 |
|
|
2018
Q3 | $3K | Hold |
36
| – | – | ﹤0.01% | 258 |
|
|
2018
Q2 | $3K | Hold |
36
| – | – | ﹤0.01% | 242 |
|
|
2018
Q1 | $3K | Hold |
36
| – | – | ﹤0.01% | 276 |
|
|
2017
Q4 | $3K | Hold |
36
| – | – | ﹤0.01% | 233 |
|
|
2017
Q3 | $3K | Buy |
+36
| New | +$2.74K | ﹤0.01% | 251 |
|
|
2016
Q2 | – | Sell |
-27
| Closed | -$2K | – | 57 |
|
|
2016
Q1 | $2K | Hold |
27
| – | – | ﹤0.01% | 199 |
|
|
2015
Q4 | $2K | Buy |
+27
| New | +$1.55K | ﹤0.01% | 192 |
|
Other funds holding ABBV
Moisand Fitzgerald Tamayo's ABBV Position: Q2 2026 in Review
Moisand Fitzgerald Tamayo increased its AbbVie (ABBV) stake by 23% in Q2 2026, buying an estimated $14.6K and bringing the position to 362 shares worth $91.1K. The position accounts for 0.01% of the portfolio, ranked #169.
Moisand Fitzgerald Tamayo first reported a position in ABBV in Q4 2015 and has held it in 38 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Moisand Fitzgerald Tamayo held 362 shares of AbbVie worth $91.1K as of Q2 2026.
- Moisand Fitzgerald Tamayo bought 68 AbbVie shares in Q2 2026, an estimated $14.6K.
- AbbVie made up 0.01% of Moisand Fitzgerald Tamayo's portfolio in Q2 2026, its #169 holding.
- Moisand Fitzgerald Tamayo first reported a position in AbbVie in Q4 2015 and has held it in 38 quarters since.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Moisand Fitzgerald Tamayo's 13F filing for Q2 2026, filed 13 Jul 2026.